ALDRIGHETTI, LUCA ANTONIO MARIA
 Distribuzione geografica
Continente #
AS - Asia 16.253
NA - Nord America 9.512
EU - Europa 6.286
SA - Sud America 5.495
AF - Africa 365
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 18
AN - Antartide 1
Totale 37.950
Nazione #
US - Stati Uniti d'America 9.053
SG - Singapore 7.241
BR - Brasile 4.600
CN - Cina 3.802
HK - Hong Kong 2.491
SE - Svezia 1.568
VN - Vietnam 1.558
IT - Italia 1.217
RU - Federazione Russa 839
DE - Germania 665
FI - Finlandia 373
AR - Argentina 353
IE - Irlanda 298
RO - Romania 279
GB - Regno Unito 232
AT - Austria 220
EC - Ecuador 195
IN - India 192
CA - Canada 191
MX - Messico 170
BD - Bangladesh 158
ID - Indonesia 157
ZA - Sudafrica 133
JP - Giappone 120
NL - Olanda 114
PL - Polonia 111
IQ - Iraq 99
PY - Paraguay 86
CO - Colombia 83
FR - Francia 75
ES - Italia 74
TR - Turchia 69
MA - Marocco 60
UA - Ucraina 60
VE - Venezuela 55
CL - Cile 49
EG - Egitto 44
PK - Pakistan 44
UZ - Uzbekistan 44
LT - Lituania 41
KE - Kenya 38
PE - Perù 31
UY - Uruguay 30
TN - Tunisia 27
AE - Emirati Arabi Uniti 25
SA - Arabia Saudita 25
AZ - Azerbaigian 23
NP - Nepal 22
DO - Repubblica Dominicana 21
CH - Svizzera 19
DZ - Algeria 17
HN - Honduras 17
IR - Iran 17
IL - Israele 16
KR - Corea 16
JO - Giordania 15
AU - Australia 14
BE - Belgio 14
KZ - Kazakistan 14
OM - Oman 14
MY - Malesia 13
AL - Albania 12
JM - Giamaica 11
A1 - Anonimo 10
BH - Bahrain 9
NI - Nicaragua 9
SK - Slovacchia (Repubblica Slovacca) 9
TT - Trinidad e Tobago 9
TW - Taiwan 9
GT - Guatemala 8
HU - Ungheria 8
LB - Libano 8
NO - Norvegia 8
PA - Panama 8
PH - Filippine 7
XK - ???statistics.table.value.countryCode.XK??? 7
BO - Bolivia 6
AO - Angola 5
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
CI - Costa d'Avorio 5
ET - Etiopia 5
GR - Grecia 5
KG - Kirghizistan 5
KW - Kuwait 5
LV - Lettonia 5
LY - Libia 5
MK - Macedonia 5
CG - Congo 4
CR - Costa Rica 4
GA - Gabon 4
GY - Guiana 4
KH - Cambogia 4
LU - Lussemburgo 4
MD - Moldavia 4
PS - Palestinian Territory 4
RS - Serbia 4
SY - Repubblica araba siriana 4
TH - Thailandia 4
AM - Armenia 3
Totale 37.881
Città #
Dallas 3.810
Singapore 3.125
Hong Kong 2.479
Shanghai 1.047
Hefei 984
Ashburn 852
Lawrence 740
Princeton 740
Ho Chi Minh City 638
Beijing 418
São Paulo 341
Hanoi 307
Helsinki 297
Dublin 296
Milan 283
Los Angeles 247
New York 235
Nuremberg 223
Moscow 188
Rio de Janeiro 147
Boardman 129
Rome 127
Munich 116
Vienna 108
Warsaw 99
Belo Horizonte 92
Brasília 90
Tokyo 86
Curitiba 74
Guayaquil 69
Da Nang 68
Montreal 68
Santa Clara 67
Stockholm 67
Campinas 66
Johannesburg 66
Quito 65
Denver 59
London 58
Orem 57
Brooklyn 56
Haiphong 55
Porto Alegre 55
Chennai 54
Guangzhou 54
Poplar 54
Biên Hòa 53
Chicago 53
Mexico City 52
Atlanta 51
Toronto 50
Guarulhos 49
Salvador 49
Houston 47
Cesano Boscone 46
Boston 45
Tashkent 42
Amsterdam 38
Turku 38
Lappeenranta 36
Fortaleza 35
Santo André 35
Phoenix 34
Baghdad 33
Frankfurt am Main 33
Recife 33
Ribeirão Preto 33
Buenos Aires 32
Goiânia 32
San Francisco 32
Thái Bình 32
Manaus 31
Seattle 30
Jakarta 29
Nairobi 29
Bologna 28
Washington 27
Can Tho 26
Council Bluffs 26
Dhaka 26
Manchester 26
Sorocaba 26
Asunción 25
Brescia 25
Cape Town 25
Maceió 25
Naples 25
Nova Iguaçu 25
Tianjin 25
Ankara 24
Cairo 24
Caxias do Sul 24
Juiz de Fora 24
Sumaré 24
Baku 23
Hải Dương 23
São Bernardo do Campo 23
Contagem 22
Montevideo 22
Mumbai 22
Totale 21.103
Nome #
111In-octreotide SPECT in occult carcinoid tumors 1.360
A prognostic model for use before elective surgery to estimate the risk of postoperative pulmonary complications (GSU-Pulmonary Score): a development and validation study in three international cohorts 198
[Clinical value of spleen autograft]. FT Considerazioni sul valore clinico dell'autoinnesto di milza 153
[Conservative treatment of postoperative pancreatic fistula. Role of interventional radiology]. FT Trattamento conservativo della fistola pancreatica postoperatoria. Ruolo della radiologia interventistica 145
. Il trapianto di isole pancreatiche come alternativa alla terapia sostitutiva insulinica intensiva nei pazienti affetti da diabete mellito di tipo 1: l'esperienza dell'Istituto Scientifico San Raffale di Milano 141
[Continuous 24-hour intragastric pH monitoring. A new model of interpretation]. FT La pHmetria endogastrica continua sulle 24 ore. Nuovo modello d'interpretazione 137
18 casi di incidentaloma della colecisti: analisi della casistica di un singolo centro 130
A comparison between robotic, laparoscopic and open hepatectomy: A systematic review and network meta-analysis 129
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 126
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 124
[Is the surgical treatment of spontaneous bacterial peritonitis still up-to-date?]. FT Trattare chirurgicamente la peritonite batterica spontanea e ancora attuale? 124
"Technological" approach versus clamp crushing technique for hepatic parenchymal transection: A comparative study 124
[Intestinal occlusion in cocaine-packet ingestion]. FT L'occlusione intestinale nella cocaine-packet ingestion 123
A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence 119
[Role of totally implantable systems for long-term vascular access in the treatment of the neoplastic patient]. FT Ruolo dei sistemi totalmente impiantabili per accesso vascolare a lungo termine nel trattamento del paziente neoplastico 119
[Impact of preoperative locoregional chemotherapy with fluorodeoxyuridine on the outcome of liver resection]. FT Impatto della chemioterapia locoregionale preoperatoria con fluorodesossiuridina (FUDR) sulla chirurgia resettiva epatica 118
30 cases of "two stage hepatectomy” for liver metastases from colorectal cancer: a single centre experience 115
[Advanced age as risk factor in liver resection surgery]. FT L'eta avanzata come fattore di rischio nella chirurgia resettiva epatica 114
[Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases]. FT Fattori prognostici dell'outcome a lungo termine della chirurgia resettiva epatica per metastasi da carcinoma colorettale 113
A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size 112
A comprehensive preoperative predictive score for post-hepatectomy liver failure after hepatocellular carcinoma resection based on patient comorbidities, tumor burden, and liver function: the CTF score 109
[Hepatic resection of metastasis of colorectal carcinoma: analysis of long-term prognostic factors of outcome]. FT Resezioni epatiche per metastasi da carcinoma colorettale: analisi dei fattori prognostici di outcome a lungo termine 103
Recommendations for laparoscopic liver resection: A report from the second international consensus conference held in morioka 102
Chromatin Velocity reveals epigenetic dynamics by single-cell profiling of heterochromatin and euchromatin 101
[Multimodal approach to rectal carcinoma with hepatic metastasis]. FT Approccio multimodale al carcinoma del retto con metastasi epatica 100
Liver Histology Predicts Liver Regeneration and Outcome in ALPPS: Novel Findings From A Multicenter Study 97
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 95
Minimally invasive approach for liver resections in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis: shifting the paradigm? Long-term Outcomes from an International Multicentre Study 95
A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma 88
Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions 86
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 84
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 81
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 78
Combined Loco-Regional and Systemic Treatment Strategies for Hepatocellular Carcinoma: From Basics to New Developments 75
Comparison of CMV reactivation after islet-kidney, pancreas-kidney or kidney alone transplantation in diabetic patients 75
Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study 73
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 72
Comparison between percutaneous and laparoscopic microwave ablation of hepatocellular carcinoma 72
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib 71
Preoperative MRI radiomic analysis for predicting local tumor progression in colorectal liver metastases before microwave ablation 70
Utilizzo combinato di dissettore ad ultrasuoni e bisturi armonico nella chirurgia resettiva epatica: esperienza su 100 resezioni epatiche 70
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 70
Combining Laparoscopic Liver Partitioning and Simultaneous Portohepatic Venous Deprivation for Rapid Liver Hypertrophy 69
The Impact of Postoperative Ascites on Survival After Surgery for Hepatocellular Carcinoma: a National Study 68
A “cui prodest” evaluation on the development of a minimally invasive liver surgery program: a differential benefit analysis of open and laparoscopic approach for left and right hemihepatectomies 67
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 66
Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma 66
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 66
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 66
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance to human islet transplantation 66
Performance of prognostic scores and staging systems in predicting long-term survival outcomes after surgery for intrahepatic cholangiocarcinoma 66
Single-Center Retrospective Study Comparing Double Vein Embolization via a Trans-Jugular Approach with Liver Venous Deprivation via a Trans-Hepatic Approach 65
Perioperative and oncologic outcomes of open radical nephrectomy and inferior vena cava thrombectomy with liver mobilization and Pringle maneuver for Mayo III level tumor thrombus: single institution experience 65
Predictors and Prognostic Significance of Postoperative Complications for Patients with Intrahepatic Cholangiocarcinoma 64
Performance of comprehensive complication index and clavien‐dindo complication scoring system in liver surgery for hepatocellular carcinoma 64
Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab 63
The failure to rescue factor: aftermath analyses on 224 cases of perihilar cholangiocarcinoma 62
Navigator nurse implementation within a fast track program of liver resections: How to improve the healthcare service and perioperative results 62
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 62
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US 62
ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study 62
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 62
Perihilar Cholangiocarcinoma - Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers 62
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population 61
Case-Matched Analysis of Totally Laparoscopic Versus Open Liver Resection for HCC: Short and Middle Term Results 61
A Nomogram to Predict Long-term Survival After Resection for Intrahepatic Cholangiocarcinoma An Eastern and Western Experience 61
A stepwise learning curve to define the standard for technical improvement in laparoscopic liver resections: complexity-based analysis in 1032 procedures 61
Achievement of textbook outcome after hepatectomy combined with thermal ablation for colorectal liver metastases 61
ASO Author Reflections: Surgical Strategy for Perihilar Cholangiocarcinoma 60
Retrospective Evaluation and Significance of Neutrophil-to-Lymphocyte Ratio Prior to and 1 month Following Microwave Ablation of Hepatocellular Carcinoma 60
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 60
Caratterizzazione della omeostasi glucidica in pazienti affetti da diabete mellito di tipo 1 un anno dopo il trapianto di isole pancreatiche 60
The complication-overall survival (CompOS) risk tool predicts risk of a severe postoperative complications relative to long-term survival among patients with primary liver cancer 59
ASO Author Reflections: Cirrhosis and Severity of Cirrhosis Negatively Affects the Outcomes of Laparoscopic and Robotic Major Liver Resections for Primary Liver Malignancies 59
Comparative Analysis of Left- Versus Right-sided Resection in Klatskin Tumor Surgery: can Lesion Side be Considered a Prognostic Factor? 59
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 59
The multi-societal European consensus on the terminology, diagnosis and management of patients with synchronous colorectal cancer and liver metastases: an E-AHPBA consensus in partnership with ESSO, ESCP, ESGAR, and CIRSE 58
Radioembolization for Hepatocellular Carcinoma: a Comparison on Dual-phase Cone-beam CT, Contrast-enhanced CT (CECT) and 99mTc-macroaggregated albumin-SPECT/CT in predicting final distribution volumes and dosimetry of the post-embolization 90Y PET/CT 58
An attempt to establish and apply global benchmarks for liver resection of malignant hepatic tumors 58
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 58
ASO Author Reflections: Hypertrophic Techniques Have an Impact on the Complexity and Outcomes of Minimally Invasive Major Hepatectomies 58
EUS-GUIDED GASTROENTEROSTOMY FOR MANAGEMENT OF MALIGNANT GASTRIC OUTLET OBSTRUCTION: A PROSPECTIVE SERIES FROM THE PROTECT REGISTRY 57
Higher Postoperative Mortality and Inferior Survival After Right-Sided Liver Resection for Perihilar Cholangiocarcinoma: Left-Sided Resection is Preferred When Possible 57
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 57
Evaluation of the ACS NSQIP Surgical Risk Calculator in Elderly Patients Undergoing Hepatectomy for Hepatocellular Carcinoma 57
Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation 57
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 56
Predicting the need for step-up after EUS-guided drainage of peripancreatic fluid collections, including Quadrant-Necrosis-Infection score validation: A prospective cohort study 56
Factors Associated with and Impact of Open Conversion in Laparoscopic and Robotic Minor Liver Resections: An International Multicenter Study of 10,541 Patients 56
Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients 56
A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database 56
Biliary cystadenoma: short- and long-term outcome after radical hepatic resection 56
Bioritmo ph-metrico della secrezione gastrica 56
Correlation Between Type of Retrieval Incision and Postoperative Outcomes in Laparoscopic Liver Surgery: A Critical Assessment 56
Cholangiocarcinoma: new perspectives for new horizons 56
Long-term oncological outcomes after laparoscopic parenchyma-sparing redo liver resections for patients with metastatic colorectal cancer: a European multi-center study 56
Impact of liver cirrhosis, severity of cirrhosis and portal hypertension on the difficulty of laparoscopic and robotic minor liver resections for primary liver malignancies in the anterolateral segments 56
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 55
Appraisal of disease-specific benefits of minimally invasiveness in surgery of breast cancer liver metastases 55
Overall Tumor Burden Dictates Outcomes for Patients Undergoing Resection of Multinodular Hepatocellular Carcinoma Beyond the Milan Criteria 55
Totale 9.183
Categoria #
all - tutte 301.870
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 301.870


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 12 2 5 0 2 2 1
2021/2022402 1 0 1 153 18 40 59 52 29 15 9 25
2022/20233.701 1.842 578 182 28 50 342 314 199 105 23 23 15
2023/20241.498 39 31 119 95 96 177 55 111 7 95 167 506
2024/202512.456 1.613 325 142 155 267 986 1.642 1.081 2.370 1.904 875 1.096
2025/202620.646 2.611 3.697 4.689 6.017 2.787 845 0 0 0 0 0 0
Totale 39.390